Description: Silymarin is indicated as adjunctive therapy in the treatment of liver disease of varying etiologies; acute hepatitis, chronic persistent and chronic aggressive hepatitis, cirrhosis of the liver, fatty liver, toxic metabolic or toxic metabolic liver damage.